4376 J. Am. Chem. Soc., Vol. 121, No. 18, 1999
Aranyos et al.
1495, 1256. Anal. Calcd for C16H18O: C, 84.91; H, 8.02. Found: C,
84.67; H, 8.03.
4-Phenoxyacetophenone (Table 1, Entry 1).30,31 General procedure
A (workup method 2, ligand 3) was used to convert 4-bromoacetophe-
none and phenol in 16 h to 188 mg (89%) of the title compound, which
was obtained as a white solid, mp 50-51 °C (lit.30 mp 51 °C).
4-(2′-Methylphenoxy)acetophenone (Table 1, Entry 2).35 General
procedure A (workup method 2, ligand 3) was used to convert
4-bromoacetophenone and o-cresol in 15 h to 213 mg (96%) of the
title compound, which was obtained as a white solid, mp 34.5-35.5
°C (lit.35 oil). 1H NMR (CDCl3, 300 MHz) δ 7.94-7.89 (m, 2H), 7.30-
7.12 (m, 3H), 6.99 (broad d, 1H, J ) 7.5 Hz), 6.91-6.87 (m, 2H),
2.57 (s, 3H), 2.19 (s, 3H); 13C NMR (CDCl3, 125 MHz) δ 196.5, 162.1,
152.8, 131.6, 131.2, 130.5, 130.4, 127.4, 125.2, 120.9, 115.8, 26.5,
16.2; IR (neat, cm-1) 1675. Anal. Calcd for C15H14O2: C, 79.62; H,
6.24. Found: C, 79.75; H, 6.55.
4-(2′-Methylphenoxy)acetophenone (Table 1, Entry 8).35 General
procedure A (workup method 2, ligand 3) was used to convert
4-acetylphenyl triflate and o-cresol in 14 h to 188 mg (83%) of the
title compound as a white solid, mp 35-36 °C (lit.35 oil). See data
above (Table 1, entry 2).
3-(2′-Methylphenoxy)acetophenone (Table 1, Entry 9). General
procedure A (workup method 2, ligand 3) was used to convert
3′-bromoacetophenone and o-cresol in 19 h to 170 mg (75%) of the
title compound, which was obtained as a colorless oil. 1H NMR (CDCl3,
300 MHz) δ 7.63 (ddd, 1H, J ) 8.0, 1.5, 1.0 Hz), 7.49 (dd, 1H, J )
2.6, 1.5 Hz), 7.39 (t, 1H, J ) 8.0 Hz), 7.27 (broad d, 1H, J ) 7.3 Hz),
7.19 (dt, 1H, J ) 7.3, 1.5 Hz), 7.11 (dd, 1H, J ) 8.0, 1.5 Hz), 7.09
(ddd, 1H, J ) 8.0, 2.6, 1.0 Hz), 6.91 (dd, 1H, J ) 8.0, 1.5 Hz), 2.57
(s, 3H), 2.23 (s, 3H); 13C NMR (CDCl3, 125 MHz) δ 197.8, 158.5,
154.0, 139.0, 131.9, 130.3, 130.1, 127.6, 124.8, 122.5, 121.9, 120.1,
116.8, 27.0, 16.4; IR (neat, cm-1) 1686, 1578, 1437, 1264. Anal. Calcd
for C15H14O2: C, 79.62; H, 6.24. Found: C, 80.02; H, 6.28.
2,2′,5-Trimethyldiphenyl Ether (Table 2, Entry 1).4 General
procedure A (workup method 1, ligand 4) was used to convert 2-bromo-
p-xylene and o-cresol in 24 h to 206 mg (96%) of the title compound
which was obtained as a colorless oil.
4-(2′-Methylphenoxy)acetophenone (Table 1, Entry 2, using 0.1
mol % Pd).35 General procedure A (workup method 2, ligand 3) was
employed, with the following changes in the amount of materials
used: palladium acetate (1.0 mg, 0.004 mmol, 0.10 mol %), ligand 3
(2.0 mg, 0.007 mmol, 0.15 mol %), 4-bromoacetophenone (890 mg,
4.47 mmol), o-cresol (0.55 mL, 5.33 mmol), potassium phosphate (1.90
g, 8.95 mmol) in toluene (13 mL) for 24 h. The title compound (955
mg, 95%) was obtained as a white solid, mp 34.5-35.5 °C (lit.35 oil).
4-(4′-tert-Butylphenoxy)acetophenone (Table 1, Entry 3).30 Gen-
eral procedure A (workup method 2, ligand 3) was used to convert
4-bromoacetophenone and 4-tert-butylphenol in 15 h to 247 mg (92%)
of the title compound, which was obtained as a colorless oil.
Methyl 4-phenoxybenzoate (Table 1, Entry 4).32 General procedure
A (workup method 2, ligand 3) was used to convert methyl 4-bro-
mobenzoate and phenol in 24 h to 201 mg (88%) of the title compound,
which was obtained as a white solid, mp 59.5-60 °C (lit.32 mp 62.5-
63 °C).
3,5-Dimethyldiphenyl Ether (Table 2, entry 2).36 General proce-
dure A (workup method 1, ligand 5) was used to convert 5-bromo-m-
xylene and phenol in 24 h to 164 mg (83%) of the title compound,
1
which was obtained as a colorless oil. H NMR (CDCl3, 300 MHz) δ
7.35-7.30 (m, 2H), 7.11-6.98 (m, 3H), 6.74 (broad s, 1H), 6.63 (broad
s, 2H), 2.28 (broad s, 6H); 13C NMR (CDCl3, 75 MHz) δ 157.3, 157.0,
139.4, 129.5, 124.9, 122.8, 118.7, 116.5, 21.3; IR (neat, cm-1) 2919,
1584, 1490, 1218. Anal. Calcd for C14H14O: C, 84.81; H, 7.12.
Found: C, 84.78; H, 6.94.
2,3′,5′,6-Tetramethyldiphenyl Ether (Table 2, Entry 3).4 General
procedure B (workup method 1, ligand 3) was used to convert 5-bromo-
m-xylene and 2,6-dimethylphenol in 24 h to 157 mg (70%) of the title
1
compound, which was obtained as a colorless oil. H NMR (CDCl3,
N,N-Diethyl-4-(2′-methylphenoxy)benzamide (Table 1, Entry 5).
General procedure B (workup method 2, ligand 3) was used except
that palladium acetate (11 mg, 0.05 mmol, 5.0 mol %) and 3 (22 mg,
0.075 mmol, 7.5 mol %) were employed to convert 4-bromo-N,N-
diethylbenzamide and o-cresol in 22 h to 230 mg (81%) of the title
300 MHz) δ 7.12-7.03 (m, 3H), 6.62 (broad s, 1H), 6.37 (broad s,
2H), 2.24 (s, 6H), 2.13 (s, 6H); 13C NMR (CDCl3, 125 MHz) δ 157.8,
151.1, 139.4, 131.5, 128.8, 124.8, 123.1, 112.2, 21.4, 16.4; IR (neat,
cm-1) 2921, 1600, 1194. Anal. Calcd for C16H18O: C, 84.91; H, 8.02.
Found: C, 84.68; H, 8.18.
3,3′,4′,5-Tetramethyldiphenyl Ether (Table 2, Entry 4).4 General
procedure B (workup method 1, ligand 3) was used to convert 5-bromo-
m-xylene and 3,4-dimethylphenol in 24 h to 188 mg (84%) of the title
compound, which was obtained as a colorless oil.
1
compound, which was obtained as a colorless oil. H NMR (CDCl3,
300 MHz) δ 7.35-7.30 (m, 2H), 7.27-7.25 (m, 1H), 7.19 (td, 1H, J
) 8.0, 1.9 Hz), 7.10 (td, 1H, J ) 7.2, 1.2 Hz), 6.94 (dd, 1H, J ) 8.0,
1.2 Hz), 6.90-6.85 (m, 2H), 3.41 (broad s, 4H), 2.21 (s, 3H), 1.18
(broad s, 6H); 13C NMR (CDCl3, 75 MHz) δ 171.0, 158.9, 153.8, 131.7,
131.1, 130.4, 128.4, 127.4, 124.7, 120.5, 116.7, 43.0, 39.0, 16.4, 13.0;
IR (neat, cm-1) 1627, 1584, 1424, 1237. Anal. Calcd for C18H21NO2:
C, 76.28; H, 7.47. Found: C, 76.11; H, 7.42.
4-tert-Butyl-2′-methyldiphenyl Ether (Table 2, Entry 5). General
procedure A (workup method 1, ligand 3) was used to convert 4-tert-
butylbromobenzene and o-cresol in 14 h to 204 mg (85%) of the title
1
compound, which was obtained as a colorless oil. H NMR (CDCl3,
4-(3′-Isopropylphenoxy)benzonitrile (Table 1, Entry 6). General
procedure A (workup method 2, ligand 3) was used to convert p-chloro
benzonitrile and m-isopropylphenol in 24 h to 218 mg (91%) of the
300 MHz) δ 7.32 (d, 2H, J ) 9.0 Hz), 7.25 (dd, 1H, J ) 8.1, 1.5 Hz),
7.15 (dt, 1H, J ) 7.5, 1.5 Hz), 7.04 (dt, 1H, J ) 7.5, 1.2 Hz), 6.89 (dd,
1H, J ) 8.1, 1.2 Hz), 6.84 (d, 2H, J ) 9.0 Hz), 2.26 (s, 3H), 1.31 (s,
9H); 13C NMR (CDCl3, 125 MHz) δ 155.6, 155.1, 145.4, 131.5, 130.0,
1
title compound, which was obtained as a pale yellow oil. H NMR
127.2, 126.6, 123.8, 119.6, 117.2, 34.4, 31.7, 16.4; IR (neat, cm-1
)
(CDCl3, 300 MHz) δ 7.61-7.57 (m, 2H), 7.32 (t, 1H, J ) 7.8 Hz),
7.11 (d, 1H, J ) 7.8 Hz), 7.02-6.97 (m, 2H), 6.95-6.93 (m, 1H),
6.87 (ddd, 1H, J ) 8.1, 2.4, 0.9 Hz), 2.92 (sept, 1H, J ) 6.6 Hz), 1.25
(d, 6H, J ) 6.6 Hz); 13C NMR (CDCl3, 75 MHz) δ 161.7, 154.6, 151.6,
134.0, 129.9, 123.3, 118.7, 118.4, 117.7, 117.6, 105.5, 34.0, 23.9; IR
(neat, cm-1) 2962, 2227, 1245. Anal. Calcd for C16H15NO: C, 80.98;
H, 6.37. Found: C, 80.93; H, 6.64.
2929, 1586, 1237. Anal. Calcd for C17H20O: C, 84.95; H, 8.39.
Found: C, 84.84; H, 8.72.
4-n-Butyl-2′-isopropyldiphenyl Ether (Table 2, Entry 6). General
procedure A (workup method 1, ligand 3) was used to convert 1-bromo-
4-n-butylbenzene and 2-isopropylphenol in 24 h to 246 mg (92%) of
1
the title compound, which was obtained as a colorless oil. H NMR
4-Chloro-2′-isopropyldiphenyl Ether (Table 1, Entry 7). General
procedure A (workup method 1, ligand 3) was used to convert
4-cholorobromobenzene and o-isopropylphenol (260 µL, 1.95 mmol)
in 24 h to 223 mg (90%) of the title compound, which was obtained as
(CDCl3, 300 MHz) δ 7.34-7.31 (dd, 1H, J ) 7.0, 2.4 Hz), 7.13-7.06
(m, 4H), 6.86-6.82 (m, 3H), 3.31 (sept, 1H, J ) 7.0 Hz), 2.57 (t, 2H,
J ) 7.7 Hz), 1.63-1.53 (m, 2H), 1.42-1.29 (m, 2H), 1.23 (d, 6H, J )
7.0 Hz), 0.93 (t, 3H, J ) 7.3 Hz); 13C NMR (CDCl3, 75 MHz) δ 156.0,
154.0, 140.0, 136.9, 129.4, 126.7, 126.6, 123.7, 119.2, 117.6, 34.9,
33.9, 27.1, 23.0, 22.4, 14.0; IR (neat, cm-1) 2960, 1505, 1486, 1231.
Anal. Calcd for C19H24O: C, 85.03; H, 9.01. Found: C, 84.88; H, 9.06.
2-Isopropyl-4′-methoxydiphenyl Ether (Table 2, Entry 7). General
procedure A (workup method 1, ligand 6) was used to convert
p-bromoanisole and o-isopropylphenol in 24 h to 213 mg (88%) of the
1
a colorless oil. H NMR (CDCl3, 300 MHz) δ 7.38-7.33 (m, 1H),
7.28-7.23 (m, 2H), 7.20-7.12 (m, 2H), 6.90-6.82 (m, 3H), 3.25 (sept,
1H, J ) 6.9 Hz), 1.22 (d, 6H, J ) 6.9 Hz); 13C NMR (CDCl3, 75
MHz) δ 156.9, 153.0, 140.2, 129.5, 127.15, 127.05, 126.9, 124.5, 119.8,
118.5, 27.1, 23.0; IR (neat, cm-1) 2964, 1482, 1092. Anal. Calcd for
C15H15ClO: C, 73.02; H, 6.13. Found: C, 73.00; H, 5.86.
(35) Horii, Z.; Kiuchi, T. J. Pharm. Soc. Jpn. 1937, 57, 683-688; Chem.
Abstr. 1938, 129.
(36) Smith, K.; Jones, D. J. Chem. Soc., Perkin Trans. 1 1992, 407-
408.